Preliminary reports suggest conolidine may possibly inhibit specific ion channels, decreasing neuronal excitability and limiting agony alerts. This system is particularly applicable in neuropathic ache, wherever irregular signaling leads to persistent discomfort. On top of that, conolidine seems to affect G protein-coupled receptor (GPCR) pathways